Time: 3:42

Peter Mac joins…

The Melbourne-based Peter MacCallum Cancer Centre has become the first Australian representative on Bristol-Myers Squibb’s International Immuno-Oncology Network. The peer-to-peer global network, comprised of 15 members including over 250 researchers and clinicians, aims to accelerate the development of cancer immunotherapies. Bristol-Myers Squibb has been at…

Read More...
Peter Mac joins BMS global immuno-oncology network
The Melbourne-based Peter MacCallum Cancer Centre has become the first Australian representative on Bristol-Myers Squibb’s International Immuno-Oncology…

TGA approval for…

The TGA has approved CSL Behring’s ZEMAIRA for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). AATD is a hereditary condition that can severely affect a patient’s lung function. The condition is marked by a low level or absence of Alpha-1 Proteinase Inhibitor…

Read More...
TGA approval for CSL Behring lung therapy
The TGA has approved CSL Behring’s ZEMAIRA for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). AATD is…

Sinodinos announces intention…

The newly-appointed Minister for Industry, Innovation and Science, Senator Arthur Sinodinos, has announced an intention to establish a women’s advisory to guide policy in the innovation sector. Addressing the Women in Venture Capital Forum last week in Sydney, the Minister said…

Read More...
Sinodinos announces intention for women’s advisory roundtable
The newly-appointed Minister for Industry, Innovation and Science, Senator Arthur Sinodinos, has announced an intention…

Latest News

28 February 2017Latest News

Peter Mac joins BMS global immuno-oncology network

The Melbourne-based Peter MacCallum Cancer Centre has become the first Australian representative on Bristol-Myers Squibb’s International Immuno-Oncology Network. The peer-to-peer global network, comprised…

28 February 2017Company News

TGA approval for CSL Behring lung therapy

The TGA has approved CSL Behring’s ZEMAIRA for the treatment of Alpha-1…

28 February 2017AusBiotech

Sinodinos announces intention for women’s advisory roundtable

The newly-appointed Minister for Industry, Innovation and Science, Senator Arthur…

28 February 2017Company News

New chairman for Cynata Therapeutics

Australian stem cell and regenerative medicine company, Cynata Therapeutics (ASX:CYP), has announced the appointment of current non-executive director Dr Paul Wotton…

28 February 2017Company News

Innate MS trial on schedule for April…

Innate Immunotherapeutics (ASX:IIL) has confirmed the clinical phase of the…

23 February 2017Latest News

WA Labor commits to medical research future…

WA Labor has committed to invest interest generated from the…

23 February 2017AusBiotech

Uncertainty on R&D Tax Incentive causing harm

Constant reviews and recent changes to the Research and Development…

23 February 2017Latest News

Company secures first cannabis licence as government acts on special access

The Office of Drug Control has issued the first licence under Australia’s new medicinal cannabis regulatory system as health minister Greg…

23 February 2017Company News

PolyNovo reports first patient treated in US

PolyNovo (ASX:PNV) has announced the first US patient has been treated…